Korea Forum: Introduction to the Korean Ministry of Food and Drug Safety (MFDS) and Government R&D Program
Track
:
Track 18: Global Regulatory
Program Code:
286
Date:
Tuesday, June 25, 2013
Time:
4:00 PM to 5:30 PM
EST
Location:
257AB
CHAIR
:
Yil-Seob Lee, MD,PhD,MBA (SCHNON), Executive Member, Korea National Enterprise for Clinical Trials (KoNECT)Korea, Republic of
Yil-Seob Lee is currently working for GSK Korea as a head of Medical & Regulatory, and is also working as a vice president of Korean Society of Clinical Pharmacology & Therapeutics and an affiliated professor in Yonsei University, Graduate School of Public Health in Seoul, Korea.
SPEAKER
(S):
Kyung-Sang Yu, MD,PhD,MBA (SPKSUP), Associate Professor, Clinical Pharmacology, Seoul National University College of Medicine, Korea, Republic of
Dr. Yu is working as Associate Professor of Clinical Pharmacology and Therapeutics at Seoul National University College of Medicine and Hospital, and is also an executive member of KoNECT, Korea National Enterprise for Clinical Trials.
Jeewon Joung, PhD (SPKAGY), Deputy Director, Korean Ministry of Food and Drug Safety (MFDS), Korea, Republic of
Dr, Jeewon Joung have been working for KFDA since 1993. She is responsible for review and licensure of recombinant DNA derived product.
Tae Kyun Nam, MPharm (SPKAGY), Deputy Director, Korean Ministry of Food and Drug Safety (MFDS), Korea, Republic of
Description
The Korean Ministry of Food and Drug Safety (MFDS) (formerly the KFDA) has evolved rapidly as one of the leading regulatory agencies in Asia, and the Korean government is initiating several R&D program to promote clinical development. This forum will discuss the current regulatory system and practices from the MFDS and government R&D program.